SONYA SPENCER: Open Payments
NPI 1962101204 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 50 payments from 16 companies in 2025. Trend: 2023 $227 · 2024 $661 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $491 |
| Corcept Therapeutics | 6 | $126 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Astellas Pharma US Inc | 1 | $24 |
| Ascensia Diabetes Care Us Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, UBRELVY, QULIPTA, Korlym, SHINGRIX, CAPLYTA, JARDIANCE, SAPIEN 3 Ultra RESILIA.
Industry payments across UT — which companies pay providers there.
